Biotech research

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Biotech Stocks

Novartis AG (ADR) (NYSE:NVS) Enbrel Biosimilar Erelzi Approved In Europe

Here’s What Lipocine Inc. (NASDAQ:LPCN)’s Latest Announcement Means For Shareholders

Cellectis SA (ADR) (NASDAQ:CLLS) Just Made A Big Step Forward In CAR-T

Mazor Robotics Ltd – ADR (NASDAQ:MZOR) Obtains An FDA Nod For Its Spinal Deformity Corrections Software

China MediTech And AstraZeneca Plc (NYSE: AZN) To Present Savolitinib Phase II Results At The Genitourinary Cancers Symposium 2017

GlaxoSmithKline plc (ADR) (NYSE:GSK) And Rolls Royce To Expect UK Fraud...

Progress Reported On The Partnership Between Mazor Robotics Ltd – ADR...

CVS Health Corp (NYSE:CVS) Affirms Patient Care Ambitions With New Diabetes...

AbbVie Inc. (NYSE:ABBV) Shrugs Of Humira Dependence Concerns With Robust Pipeline

Gilead Sciences, Inc. (NASDAQ:GILD), Sanofi SA (ADR) (NYSE:SNY) Eyeing TESARO Inc...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Targeting $500Million-$1 Billion On Medis...

Why FDA Panel Backed Novartis AG (ADR) (NYSE:NVS) Leukemia Drug

Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Maviret Authorized For Sale In EU

Generic Drug Prices Expected To Keep Falling As Walgreens Boots Alliance...

Here’s What’s Important About The July Kala Pharmaceuticals Inc (NASDAQ:KALA) IPO

EDITOR PICKS

Wednesday’s Pipeline Movers: Bristol-Myers Squibb Company (NYSE:BMY) and Portola Pharmaceuticals Inc....

Two Failed Trials: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and Regeneron Pharmaceuticals, Inc....

Biotech Movers: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

POPULAR POSTS

This Small Nasdaq Hidden Gem May Have a $2.8B Drug

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

POPULAR CATEGORY